A genomic classifier to improve prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
暂无分享,去创建一个
M. Kattan | C. Magi-Galluzzi | E. Klein | K. Yousefi | E. Davicioni | V. Choeurng | A. Stephenson | C. Buerki | Z. Haddad | Jianbo Li